Skip to main content
. 2019 Oct 25;10:2514. doi: 10.3389/fimmu.2019.02514

Figure 3.

Figure 3

Tumor growth inhibition assay on a panel of TRAIL-R2-positive or negative cells. ScDb-dependent PBL-mediated growth inhibition was performed on several cancer cell lines using scDb concentrations of 0, 0.05, 0.1, 0.5, and 1 μg/mL and an E:T ratio of 5:1 for 48 h (black line) or 96 h (gray line). Non-activated PBLs were used as effectors. The graph represents the mean ± SD of three experiments. In each graph the expression level of TRAIL-R2 as mean fluorescence intensity (MFI) is reported.